297 related articles for article (PubMed ID: 21628462)
1. Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors.
Guillon-Munos A; Oikonomopoulou K; Michel N; Smith CR; Petit-Courty A; Canepa S; Reverdiau P; Heuzé-Vourc'h N; Diamandis EP; Courty Y
J Biol Chem; 2011 Jul; 286(29):25505-18. PubMed ID: 21628462
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesis.
Pasmant E; Ortonne N; Rittié L; Laurendeau I; Lévy P; Lazar V; Parfait B; Leroy K; Dessen P; Valeyrie-Allanore L; Perbal B; Wolkenstein P; Vidaud M; Vidaud D; Bièche I
J Neuropathol Exp Neurol; 2010 Jan; 69(1):60-9. PubMed ID: 20010302
[TBL] [Abstract][Full Text] [Related]
3. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
[TBL] [Abstract][Full Text] [Related]
4. Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis.
Yoon H; Blaber SI; Evans DM; Trim J; Juliano MA; Scarisbrick IA; Blaber M
Protein Sci; 2008 Nov; 17(11):1998-2007. PubMed ID: 18697857
[TBL] [Abstract][Full Text] [Related]
5. Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker.
Sato A; Takagi K; Yoshimura A; Tsukamoto W; Yamaguchi-Tanaka M; Miki Y; Ebata A; Miyashita M; Suzuki T
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176127
[TBL] [Abstract][Full Text] [Related]
6. Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review).
Li J; Ye L; Owen S; Weeks HP; Zhang Z; Jiang WG
Int J Mol Med; 2015 Dec; 36(6):1451-63. PubMed ID: 26498181
[TBL] [Abstract][Full Text] [Related]
7. A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.
Planque C; Li L; Zheng Y; Soosaipillai A; Reckamp K; Chia D; Diamandis EP; Goodglick L
Clin Cancer Res; 2008 Mar; 14(5):1355-62. PubMed ID: 18316555
[TBL] [Abstract][Full Text] [Related]
8. Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.
Memari N; Diamandis EP; Earle T; Campbell A; Van Dekken H; Van der Kwast TH
Prostate; 2007 Sep; 67(13):1465-74. PubMed ID: 17654496
[TBL] [Abstract][Full Text] [Related]
9. The CCN family: a new stimulus package.
Brigstock DR
J Endocrinol; 2003 Aug; 178(2):169-75. PubMed ID: 12904165
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis stimulated by human kallikrein-related peptidase 12 acting via a platelet-derived growth factor B-dependent paracrine pathway.
Kryza T; Achard C; Parent C; Marchand-Adam S; Guillon-Munos A; Iochmann S; Korkmaz B; Respaud R; Courty Y; Heuzé-Vourc'h N
FASEB J; 2014 Feb; 28(2):740-51. PubMed ID: 24225148
[TBL] [Abstract][Full Text] [Related]
11. Kallikrein-related peptidases in lung diseases.
Lenga Ma Bonda W; Iochmann S; Magnen M; Courty Y; Reverdiau P
Biol Chem; 2018 Sep; 399(9):959-971. PubMed ID: 29604204
[TBL] [Abstract][Full Text] [Related]
12. Kallikreins as microRNA targets: an in silico and experimental-based analysis.
Chow TF; Crow M; Earle T; El-Said H; Diamandis EP; Yousef GM
Biol Chem; 2008 Jun; 389(6):731-8. PubMed ID: 18627289
[TBL] [Abstract][Full Text] [Related]
13. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer.
Chen PP; Li WJ; Wang Y; Zhao S; Li DY; Feng LY; Shi XL; Koeffler HP; Tong XJ; Xie D
PLoS One; 2007 Jun; 2(6):e534. PubMed ID: 17579708
[TBL] [Abstract][Full Text] [Related]
14. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.
Gery S; Xie D; Yin D; Gabra H; Miller C; Wang H; Scott D; Yi WS; Popoviciu ML; Said JW; Koeffler HP
Clin Cancer Res; 2005 Oct; 11(20):7243-54. PubMed ID: 16243794
[TBL] [Abstract][Full Text] [Related]
15. CCN5, a novel transcriptional repressor of the transforming growth factor β signaling pathway.
Sabbah M; Prunier C; Ferrand N; Megalophonos V; Lambein K; De Wever O; Nazaret N; Lachuer J; Dumont S; Redeuilh G
Mol Cell Biol; 2011 Apr; 31(7):1459-69. PubMed ID: 21262769
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6.
Kantyka T; Fischer J; Wu Z; Declercq W; Reiss K; Schröder JM; Meyer-Hoffert U
Peptides; 2011 Jun; 32(6):1187-92. PubMed ID: 21439340
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor pathway inhibitor 2 is a potent kallikrein-related protease 12 inhibitor.
Lavergne M; Guillon-Munos A; Lenga Ma Bonda W; Attucci S; Kryza T; Barascu A; Moreau T; Petit-Courty A; Sizaret D; Courty Y; Iochmann S; Reverdiau P
Biol Chem; 2021 Sep; 402(10):1257-1268. PubMed ID: 33977679
[TBL] [Abstract][Full Text] [Related]
18. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells.
Si W; Kang Q; Luu HH; Park JK; Luo Q; Song WX; Jiang W; Luo X; Li X; Yin H; Montag AG; Haydon RC; He TC
Mol Cell Biol; 2006 Apr; 26(8):2955-64. PubMed ID: 16581771
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic properties of human kallikrein-related peptidase 12 (KLK12).
Memari N; Jiang W; Diamandis EP; Luo LY
Biol Chem; 2007 Apr; 388(4):427-35. PubMed ID: 17391064
[TBL] [Abstract][Full Text] [Related]
20. Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin.
Emami N; Diamandis EP
J Biol Chem; 2008 Feb; 283(6):3031-3041. PubMed ID: 18056261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]